Free Access
Med Sci (Paris)
Volume 31, Number 11, Novembre 2015
Page(s) 989 - 995
Section M/S Revues
Published online 17 November 2015
  1. Azzi S, Gavard J. Vaisseaux sanguins et tumeurs ou l’art du dialogue. Med Sci (Paris) 2014 ; 30 : 408–414. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Wacker A, Gerhardt H. Endothelial development taking shape. Curr Opin Cell Biol 2011 ; 23 : 676–685. [PubMed] [Google Scholar]
  3. Hellstrom M, Phng LK, Hofmann JJ, et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 2007 ; 445 : 776–780. [CrossRef] [PubMed] [Google Scholar]
  4. Suchting S, Freitas C, le Noble F, et al. The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc Natl Acad Sci USA 2007 ; 104 : 3225–3230. [CrossRef] [Google Scholar]
  5. Jakobsson L, Franco CA, Bentley K, et al. Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting. Nat Cell Biol 2010 ; 12 : 943–953. [CrossRef] [PubMed] [Google Scholar]
  6. Tammela T, Zarkada G, Wallgard E, et al. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 2008 ; 454 : 656–660. [CrossRef] [PubMed] [Google Scholar]
  7. Phng LK, Stanchi F, Gerhardt H. Filopodia are dispensable for endothelial tip cell guidance. Development 2013 ; 140 : 4031–4040. [CrossRef] [PubMed] [Google Scholar]
  8. Gavard J, Gutkind JS. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 2006 ; 8 : 1223–1234. [CrossRef] [PubMed] [Google Scholar]
  9. Le Guelte A, Galan-Moya EM, Dwyer J, et al. Semaphorin 3A elevates endothelial cell permeability through PP2A inactivation. J Cell Sci 2012 ; 125 : 4137–4146. [CrossRef] [PubMed] [Google Scholar]
  10. Dwyer J, Hebda JK, Le Guelte A, et al. Glioblastoma cell-secreted interleukin-8 induces brain endothelial cell permeability via CXCR2. PLoS One 2012 ; 7 : e45562. [CrossRef] [PubMed] [Google Scholar]
  11. Bentley K, Franco CA, Philippides A, et al. The role of differential VE-cadherin dynamics in cell rearrangement during angiogenesis. Nat Cell Biol 2014 ; 16 : 309–321. [CrossRef] [PubMed] [Google Scholar]
  12. De Bock K, Georgiadou M, Schoors S, et al. Role of PFKFB3-driven glycolysis in vessel sprouting. Cell 2013 ; 154 : 651–663. [CrossRef] [PubMed] [Google Scholar]
  13. Iruela-Arispe ML, Davis GE. Cellular and molecular mechanisms of vascular lumen formation. Dev Cell 2009 ; 16 : 222–231. [CrossRef] [PubMed] [Google Scholar]
  14. Zovein AC, Luque A, Turlo KA, et al. Beta1 integrin establishes endothelial cell polarity and arteriolar lumen formation via a Par3-dependent mechanism. Dev Cell 2010 ; 18 : 39–51. [CrossRef] [PubMed] [Google Scholar]
  15. Gavard J, Patel V, Gutkind JS. Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev Cell 2008 ; 14 : 25–36. [CrossRef] [PubMed] [Google Scholar]
  16. Fukuhara S, Sako K, Minami T, et al. Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1. Nat Cell Biol 2008 ; 10 : 513–526. [CrossRef] [PubMed] [Google Scholar]
  17. Ricard N, Simons M. When it is better to regress: dynamics of vascular pruning. PLoS Biol 2015 ; 13 : e1002148. [CrossRef] [PubMed] [Google Scholar]
  18. Folkman J. Angiogenesis. Annu Rev Med 2006 ; 57 : 1–18. [CrossRef] [PubMed] [Google Scholar]
  19. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011 ; 144 : 646–674. [CrossRef] [PubMed] [Google Scholar]
  20. Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011 ; 473 : 298–307. [CrossRef] [PubMed] [Google Scholar]
  21. Azzi S, Hebda JK, Gavard J. Vascular permeability and drug delivery in cancers. Front Oncol 2013 ; 3 : 211. [CrossRef] [PubMed] [Google Scholar]
  22. Dreher MR, Liu W, Michelich CR, et al. Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. J Natl Cancer Inst 2006 ; 98 : 335–344. [CrossRef] [PubMed] [Google Scholar]
  23. Inai T, Mancuso M, Hashizume H, et al. Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. Am J Pathol 2004 ; 165 : 35–52. [CrossRef] [PubMed] [Google Scholar]
  24. Sapieha P, Zaniolo K, Hamel D, et al. L’offre et la demande : l’influence du métabolisme énergétique sur l’angiogenèse. Med Sci (Paris) 2009 ; 25 : 346–348. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  25. Gothie E, Pouyssegur J. HIF-1: régulateur central de l’hypoxie. Med Sci (Paris) 2002 ; 18 : 70–78. [CrossRef] [EDP Sciences] [Google Scholar]
  26. Calabrese C, Poppleton H, Kocak M, et al. A perivascular niche for brain tumor stem cells. Cancer Cell 2007 ; 11 : 69–82. [CrossRef] [PubMed] [Google Scholar]
  27. Galan-Moya EM, Le Guelte A, Fernandes EL, et al. Secreted factors from brain endothelial cells maintain glioblastoma stem-like cell expansion through the mTOR pathway. EMBO Rep 2011 ; 12 : 470–476. [CrossRef] [PubMed] [Google Scholar]
  28. Paez-Ribes M, Allen E, Hudock J, et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 2009 ; 15 : 220–231. [CrossRef] [PubMed] [Google Scholar]
  29. Ebos JM, Lee CR, Cruz-Munoz W, et al. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 2009 ; 15 : 232–239. [CrossRef] [PubMed] [Google Scholar]
  30. Carmeliet P, Jain RK. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov 2011 ; 10 : 417–427. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.